Skyepharma Competitors and Similar CompaniesClear all
Skyepharma's competitors and similar companies include Societal CDMO, Array BioPharma, Amicus Therapeutics and Tricida.
 Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |||
Founding Date | Founding Date 1996 | Founding Date 2006 | Founding Date 1998 | Founding Date 2002 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations South San Francisco, US HQ |
Employees | Employees 1983% decrease | Employees 21316% decrease | Employees 29843% increase | Employees 58415% increase | Employees 11914% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 97.4 m | Valuation ($) N/A | Valuation ($) 3.1 b | Valuation ($) N/A |
Employee Rating | Employee Rating 3.1 | Employee Rating 3.4 | Employee Rating 3.5 | Employee Rating 2.9 | Employee Rating 4 |
Financial | |||||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $90.2m (FY, 2022) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $329.2m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $67.1m (FY, 2022) | Cost of goods $59.4m (FY, 2018) | Cost of goods $38.6m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit $23.1m (FY, 2022) | Gross profit $114.4m (FY, 2018) | Gross profit $290.6m (FY, 2022) | Gross profit N/A |
Net income | Net income N/A | Net income ($19.9m) (FY, 2022) | Net income ($147.7m) (FY, 2018) | Net income ($236.6m) (FY, 2022) | Net income ($176.6m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88m | Total funding raised $ 157m |
For sources of this data, please see the company profile
View Company Profiles
Societal CDMO
HQ
Gainesville, US
Employees
213↓ 16% decrease
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View companyArray BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company
Tricida
HQ
South San Francisco, US
Employees
119↑ 14% increase
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View company